EP Wealth Advisors LLC Has $39.71 Million Stake in HCA Healthcare, Inc. $HCA

EP Wealth Advisors LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 103,646 shares of the company’s stock after selling 1,165 shares during the period. EP Wealth Advisors LLC’s holdings in HCA Healthcare were worth $39,707,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Park Place Capital Corp boosted its position in HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after buying an additional 1,168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of HCA Healthcare by 11.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after acquiring an additional 2,698 shares during the period. Swiss National Bank grew its position in shares of HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares during the period. Cherokee Insurance Co bought a new position in HCA Healthcare during the 2nd quarter valued at approximately $3,869,000. Finally, Harrell Investment Partners LLC grew its position in HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 0.5%

HCA Healthcare stock opened at $484.67 on Friday. The stock’s 50 day simple moving average is $465.59 and its two-hundred day simple moving average is $413.62. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $520.00. The firm has a market cap of $110.60 billion, a PE ratio of 18.73, a P/E/G ratio of 1.42 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same quarter last year, the business earned $4.90 earnings per share. The firm’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on HCA. Mizuho lifted their price objective on HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. UBS Group boosted their target price on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Cowen restated a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Robert W. Baird increased their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Truist Financial raised their target price on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Fourteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $475.95.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.